Oscar Health (NYSE:OSCR) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of Oscar Health (NYSE:OSCR) from a sell rating to a hold rating in a research note published on Wednesday, Zacks.com reports.

According to Zacks, “Oscar Health Inc. is a digital health-insurance company. Oscar Health Inc. is based in New York. “

A number of other research firms have also recently commented on OSCR. Credit Suisse Group lowered their target price on Oscar Health from $21.00 to $10.00 and set an outperform rating on the stock in a research note on Friday, January 7th. The Goldman Sachs Group started coverage on Oscar Health in a report on Tuesday, December 14th. They issued a sell rating and a $6.50 price objective for the company. Morgan Stanley decreased their price objective on Oscar Health from $22.00 to $19.00 and set an overweight rating for the company in a report on Friday, December 17th. Finally, Wells Fargo & Company lowered Oscar Health from an overweight rating to an equal weight rating and decreased their price objective for the stock from $25.00 to $9.00 in a report on Thursday, January 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of Hold and an average target price of $16.42.

NYSE:OSCR opened at $7.27 on Wednesday. The company has a 50 day simple moving average of $9.45 and a two-hundred day simple moving average of $14.47. Oscar Health has a fifty-two week low of $6.59 and a fifty-two week high of $37.00.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, November 10th. The company reported ($1.02) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.34). Oscar Health had a negative return on equity of 59.62% and a negative net margin of 37.53%. The company had revenue of $443.98 million for the quarter. On average, sell-side analysts expect that Oscar Health will post -3.42 EPS for the current year.

A number of hedge funds have recently bought and sold shares of the business. Thrive Capital Management LLC grew its holdings in Oscar Health by 14.5% during the 3rd quarter. Thrive Capital Management LLC now owns 37,614,286 shares of the company’s stock valued at $654,112,000 after buying an additional 4,755,222 shares in the last quarter. Baillie Gifford & Co. grew its holdings in shares of Oscar Health by 13.0% during the third quarter. Baillie Gifford & Co. now owns 14,490,597 shares of the company’s stock worth $251,993,000 after purchasing an additional 1,665,729 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Oscar Health by 25.1% during the second quarter. Vanguard Group Inc. now owns 3,584,120 shares of the company’s stock worth $77,059,000 after purchasing an additional 719,400 shares in the last quarter. Janus Henderson Group PLC grew its holdings in shares of Oscar Health by 1.2% during the third quarter. Janus Henderson Group PLC now owns 1,929,176 shares of the company’s stock worth $33,548,000 after purchasing an additional 22,784 shares in the last quarter. Finally, Glynn Capital Management LLC purchased a new position in shares of Oscar Health during the third quarter worth about $33,314,000. 87.04% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc provides health insurance products and services to individuals, families, and businesses in the United States. The company was formerly known as Mulberry Health Inc and changed its name to Oscar Health, Inc in January 2021. Oscar Health, Inc was founded in 2012 and is headquartered in New York, New York.

Featured Article: Understanding Specialty Certificates of Deposit

Get a free copy of the Zacks research report on Oscar Health (OSCR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.